SPY322.64-7.66 -2.32%
DIA267.58-5.23 -1.92%
IXIC10,632.99-330.65 -3.02%

Novavax Announces Upcoming Investor Conference Schedule

GAITHERSBURG, Md., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ:NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will

· 09/10/2020 07:30

GAITHERSBURG, Md., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ:NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will participate in five upcoming investor conferences. A topic of discussion will be Novavax' COVID-19 vaccine candidate, NVX-CoV2373.
 

Conference details are as follows:

Citi 15th Annual BioPharma Virtual Conference

Date:September 10, 2020
Event:Investor meetings only

H.C. Wainwright 22nd Annual Global Investment Conference

Date:September 14, 2020
Time:9:30 a.m. U.S. Eastern Time (ET)
Event:Corporate presentation and investor meetings
Live Webcast:www.novavax.com, "Investors"/ "Events"

Cantor Virtual Global Healthcare Conference

Date:September 15, 2020
Time:11:20 a.m. U.S. Eastern Time (ET)
Event:Fireside chat and investor meetings
Live Webcast:www.novavax.com, "Investors"/ "Events"

Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Date:September 16, 2020
Time:12:30 p.m. U.S. Eastern Time (ET)
Event:Fireside chat and investor meetings
Live Webcast:www.novavax.com, "Investors"/ "Events"

Leerink CyberRx Series: Vaccine Forum

Date:September 23, 2020
Time:9:00 a.m. U.S. Eastern Time (ET)
Event:Fireside chat

A replay of the presentations will also be accessible under the "Investors/Events" sectionwww.novavax.com.